| Month | csDMARDs plus denosumab (N = 21) | csDMARD therapy alone (N = 22) | Difference (csDMARDs plus denosumab − csDMARD therapy alone) | ||
---|---|---|---|---|---|---|
n | Adjusted mean [95% CI] | n | Adjusted mean [95% CI] | Adjusted mean [95% CI] P value | ||
Bone erosion depth of the 2–3 metacarpal heads, mm | 6 | 17 | − 0.46 [− 1.31, 0.39] | 25 | − 0.20 [− 0.89, 0.49] | − 0.27 [− 0.86, 0.32] P = 0.3486 |
12 | 17 | − 0.56 [− 1.41, 0.29] | 22 | − 0.20 [− 0.90, 0.49] | − 0.35 [− 0.95, 0.24] P = 0.2251 | |
Bone erosion width of the 2–3 metacarpal heads, mm | 6 | 17 | − 0.26 [− 1.10, 0.57] | 25 | − 0.06 [− 0.73, 0.61] | − 0.20 [− 0.81, 0.40] P = 0.4953 |
12 | 17 | − 0.27 [− 1.10, 0.56] | 22 | − 0.03 [− 0.70, 0.64] | − 0.24 [− 0.85, 0.38] P = 0.4364 | |
Bone erosion volume of the 2–3 metacarpal heads, mm3 | 6 | 16 | − 6.21 [− 23.89, 11.46] | 24 | − 1.71 [− 16.07, 12.66] | − 4.51 [− 16.67, 7.65] P = 0.4379 |
12 | 17 | − 6.25 [− 23.94, 11.44] | 21 | − 3.18 [− 17.56, 11.20] | − 3.07 [− 15.32, 9.17] P = 0.5979 |